AG
MDT icon

Ascent Group’s Medtronic MDT Stock Holding History

Ascent Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79M Sell
20,686
-1,068
-5% -$102K 0.06% 268
2025
Q4 		$2.09M Buy
21,754
+4,617
+27% +$448K 0.07% 236
2025
Q3 		$1.63M Sell
17,137
-21,164
-55% -$1.95M 0.06% 282
2025
Q2 		$3.34M Buy
38,301
+21,038
+122% +$1.78M 0.13% 158
2025
Q1 		$1.55M Buy
17,263
+9,180
+114% +$821K 0.07% 267
2024
Q4 		$646K Buy
8,083
+2,797
+53% +$242K 0.05% 333
2024
Q3 		$476K Buy
+5,286
New +$445K 0.04% 380
2024
Q2 		– Sell
-3,349
Closed -$292K – 522
2024
Q1 		$292K Buy
3,349
+497
+17% +$42.4K 0.03% 436
2023
Q4 		$243K Buy
+2,852
New +$217K 0.02% 448
2023
Q3 		– Sell
-8,386
Closed -$690K – 480
2023
Q2 		$690K Buy
8,386
+3,150
+60% +$271K 0.08% 274
2023
Q1 		$422K Buy
5,236
+1,686
+47% +$137K 0.04% 336
2022
Q4 		$276K Sell
3,550
-1,864
-34% -$151K 0.03% 405
2022
Q3 		$473K Buy
5,414
+1,166
+27% +$105K 0.06% 303
2022
Q2 		$393K Sell
4,248
-3,175
-43% -$322K 0.05% 345
2022
Q1 		$824K Buy
7,423
+844
+13% +$89.2K 0.1% 242
2021
Q4 		$695K Buy
+6,579
New +$762K 0.09% 248

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ascent Group's MDT Position: Q1 2026 in Review

Ascent Group reduced its Medtronic (MDT) stake by 4.9% in Q1 2026, selling an estimated $102K and leaving 20,686 shares worth $1.79M. The position accounts for 0.06% of the portfolio, ranked #268.

Ascent Group first reported a position in MDT in Q4 2021 and has held it in 16 quarters since. The position peaked at $3.34M in Q2 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Ascent Group held 20,686 shares of Medtronic worth $1.79M as of Q1 2026.
  • Ascent Group sold 1,068 Medtronic shares in Q1 2026, an estimated $102K.
  • Medtronic made up 0.06% of Ascent Group's portfolio in Q1 2026, its #268 holding.
  • Ascent Group first reported a position in Medtronic in Q4 2021 and has held it in 16 quarters since.
  • Ascent Group's Medtronic position peaked at $3.34M in Q2 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.